Alpha Penny Stocks knows Hot stocks, especially hot Small and Mid Capstocks, and knows that The RIGHT Stock can offer the HIGHEST percentage gains of any stocks in the market. At AlphaPennyStocks, we highlight and alert on the best penny stocks and value investments in stocks on any stock market. The stock picks issued at AlphaPennyStocks are the top penny stocks that we are evaluating for the best return on investment.
Scottsdale, AZ -- (SBWIRE) -- 02/13/2013 -- In the biotechnology sector, Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) was among active runners on Wednesday as the stock volume was seen topping the regular volume level in first few hours of trading session.
Peregrine Pharmaceuticals (PPHM) on Wednesday reported results from its 70 patient open-label, randomized Phase II clinical trial of bavituximab utilized in combination with gemcitabine in patients with formerly untreated, advanced Stage IV pancreatic cancer.
What does the trial held for Peregrine Pharmaceuticals? Find out here
The trial consisted of the enrollment of patients with advanced metastatic disease containing critical liver involvement and poor performance status linked with swift disease progression.
Results indicated that the combination of bavituximab and gemcitabine caused about over a doubling of overall response rates (ORR) and an enhancement in overall survival (OS) when contrasted with gemcitabine alone (control arm).
We are happy with the outcomes witnessed in this very tough to cure patient population, Kerstin Menander, MD, PhD, head of medical oncology at Peregrine stated about results.
For How Long PPHM’s Gloss will Attract Investors? Find out via this report
Wednesday session is packed with earnings announcements and companies were witnessing upward and downward movement after their earnings call.
The solar sector got an additional boost from a robust reaction from the MEMC Electronic Materials Inc. (NYSE: WFR) earnings announcement.
What made MEMC Electronic to rally to new highs? Find in this report
MEMC announced earnings that were topping experts forecasts. Earnings for the recent quarter came in $0.08 per share, against a breakeven consensus, while revenue declined nearly 9% to $704.3 million. Though sales were lower, the report was not as pessimistic as predicted, as the consensus estimation was nearly $669 million.
About Alpha Penny Stocks
Alphapennystocks.com is an Independent Company, our focus is on small cap stocks that trade on OTCBB and OTC markets, and are mostly referred to as “penny stocks”. These are stocks that normally trade under $5 a share and could offer the greatest potential return on your short or long term investment. We strive to live up to our name, Alpha, being the leader in the industry. It is important to understand that these stocks also carry high risk. You must read our Disclaimer page for more information regarding conflicts of interest and the risks involved.
We try to spot stocks in all types of market conditions. In addition, we provide emerging small cap companies with profiling and investor relations services for compensation. If you believe your company is an emerging company, with a solid product, or a company that offers our members a profitable short or long term opportunity please feel free to send us an e-mail and we’ll review the company and reply to your inquiry promptly. Please provide as much information you believe we’ll need to review your request.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)